{"DataElement":{"publicId":"6059276","version":"1","preferredName":"Endocrine System Disorder Occurrence Type","preferredDefinition":"A description of the endocrine system disorder that occurred.","longName":"6059272v1.0:6059275v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"6059272","version":"1","preferredName":"Endocrine System Disorder Occurrence","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the endocrine system. Representative examples of non-neoplastic disorders include diabetes mellitus, hyperthyroidism, and adrenal gland insufficiency. Representative examples of neoplastic disorders include carcinoid tumor, neuroendocrine carcinoma, and pheochromocytoma._An instance of something happening, such as an event or incident.","longName":"2760548v1.0:2234856v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2760548","version":"1","preferredName":"Endocrine Disorder","preferredDefinition":"Any deviation from the normal structure or function of the endocrine system that is manifested by a characteristic set of symptoms and signs.","longName":"C3009","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endocrine System Disorder","conceptCode":"C3009","definition":"A non-neoplastic or neoplastic disorder that affects the endocrine system. Representative examples of non-neoplastic disorders include diabetes mellitus, hyperthyroidism, and adrenal gland insufficiency. Representative examples of neoplastic disorders include carcinoid tumor, neuroendocrine carcinoma, and pheochromocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"501DC5C4-2250-2772-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-20","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-20","modifiedBy":"ONEDATA","dateModified":"2008-06-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234856","version":"1","preferredName":"Occurrence","preferredDefinition":"Occurrence; an instance of something happening.","longName":"C25275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-72B8-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64014C0A-2B53-644E-E053-F662850ADC94","latestVersionIndicator":"Yes","beginDate":"2018-01-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-01-30","modifiedBy":"KUMMEROA","dateModified":"2021-06-25","changeDescription":". 2021-6-25 ak Released per Janet review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6059275","version":"1","preferredName":"Endocrine System Disorder Type","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the endocrine system. Representative examples of non-neoplastic disorders include diabetes mellitus, hyperthyroidism, and adrenal gland insufficiency. Representative examples of neoplastic disorders include carcinoid tumor, neuroendocrine carcinoma, and pheochromocytoma._Something distinguishable as an identifiable class based on common qualities.","longName":"6059275v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"63FFEEE3-C683-2F69-E053-F662850AE09C","beginDate":"2018-01-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-01-30","modifiedBy":"ONEDATA","dateModified":"2018-01-30","deletedIndicator":"No"},{"value":"Diabetes","valueDescription":"Diabetes Mellitus","ValueMeaning":{"publicId":"3292684","version":"1","preferredName":"Diabetes Mellitus","longName":"3292684","preferredDefinition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetes Mellitus","conceptCode":"C2985","definition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA65AE0-D82E-3EBD-E040-BB89AD431EBC","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-06","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"63FFEEE3-C68D-2F69-E053-F662850AE09C","beginDate":"2018-01-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-01-30","modifiedBy":"ONEDATA","dateModified":"2018-01-30","deletedIndicator":"No"},{"value":"Hypothyroidism","valueDescription":"Hypothyroidism","ValueMeaning":{"publicId":"2562672","version":"1","preferredName":"Hypothyroidism","longName":"2562672","preferredDefinition":"A condition in which the production of thyroid hormone by the thyroid gland is diminished. Signs and symptoms of hypothyroidism include low metabolic rate, tendency to weight gain, somnolence and sometimes myxedema. In the United States, the most common cause of hypothyroidism is Hashimoto's thyroiditis, an autoimmune disorder. SYN athyrea. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypothyroidism","conceptCode":"C26800","definition":"Abnormally low levels of thyroid hormone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1DD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"COOPERM","dateModified":"2008-11-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"63FFEEE3-C697-2F69-E053-F662850AE09C","beginDate":"2018-01-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-01-30","modifiedBy":"ONEDATA","dateModified":"2018-01-30","deletedIndicator":"No"},{"value":"Hyperthyroidism","valueDescription":"Hyperthyroidism","ValueMeaning":{"publicId":"2946188","version":"1","preferredName":"Hyperthyroidism","longName":"2946188","preferredDefinition":"Overactivity of the thyroid gland resulting in overproduction of thyroid hormone and increased metabolic rate. Causes include diffuse hyperplasia of the thyroid gland (Graves' disease), single nodule in the thyroid gland, and thyroiditis. The symptoms are related to the increased metabolic rate and include weight loss, fatigue, heat intolerance, excessive sweating, diarrhea, tachycardia, insomnia, muscle weakness, and tremor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperthyroidism","conceptCode":"C3123","definition":"Overactivity of the thyroid gland resulting in overproduction of thyroid hormone and increased metabolic rate. Causes include diffuse hyperplasia of the thyroid gland (Graves' disease), single nodule in the thyroid gland, and thyroiditis. The symptoms are related to the increased metabolic rate and include weight loss, fatigue, heat intolerance, excessive sweating, diarrhea, tachycardia, insomnia, muscle weakness, and tremor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746BFDBA-4B32-B144-E040-BB89AD4341DF","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"63FFEEE3-C6A1-2F69-E053-F662850AE09C","beginDate":"2018-01-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-01-30","modifiedBy":"ONEDATA","dateModified":"2018-01-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6059274","version":"1","preferredName":"Endocrine System Disorder Type","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the endocrine system. Representative examples of non-neoplastic disorders include diabetes mellitus, hyperthyroidism, and adrenal gland insufficiency. Representative examples of neoplastic disorders include carcinoid tumor, neuroendocrine carcinoma, and pheochromocytoma.:Something distinguishable as an identifiable class based on common qualities.","longName":"C3009:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endocrine System Disorder","conceptCode":"C3009","definition":"A non-neoplastic or neoplastic disorder that affects the endocrine system. Representative examples of non-neoplastic disorders include diabetes mellitus, hyperthyroidism, and adrenal gland insufficiency. Representative examples of neoplastic disorders include carcinoid tumor, neuroendocrine carcinoma, and pheochromocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"63FFEEE3-C65B-2F69-E053-F662850AE09C","latestVersionIndicator":"Yes","beginDate":"2018-01-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-01-30","modifiedBy":"ONEDATA","dateModified":"2018-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"63FFEEE3-C66C-2F69-E053-F662850AE09C","latestVersionIndicator":"Yes","beginDate":"2018-01-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-01-30","modifiedBy":"KUMMEROA","dateModified":"2021-06-25","changeDescription":". 2021-6-25 ak Released per Janet review. System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Has the recipient developed endocrinopathies after HCT?","type":"Alternate Question Text","description":"Has the recipient developed endocrinopathies after HCT?","url":null,"context":"NHLBI"},{"name":"What was the endocrine system","type":"Preferred Question Text","description":"What was the endocrine system disorder that occurred?","url":null,"context":"NHLBI"},{"name":"Specify endocrinopathy","type":"Alternate Question Text","description":"Specify endocrinopathy","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"64019175-6BBC-55EA-E053-F662850AECA4","latestVersionIndicator":"Yes","beginDate":"2018-01-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-01-30","modifiedBy":"KUMMEROA","dateModified":"2021-06-25","changeDescription":". 2021-6-25 ak Release per Janet review. System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}